GSK Raises Profit Guidance
Wall Street Journal
GSK said it now expects adjusted operating profit to increase between 13-15% for the year after it reported a rise in net profit in the third quarter, mainly due to the U.S. launch of its Arexvy vaccine.
https://www.wsj.com/articles/gsk-plc-raises-guidance-after-rsv-vaccine-lifts-earnings-ca7bd091